BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sherman KE, Kang M, Sterling R, Umbleja T, Marks K, Kiser JJ, Alston-Smith B, Greaves W, Butt AA, the ACTG 5294 BIRTH Study Team. Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World J Hepatol 2017; 9(4): 217-223 [PMID: 28217259 DOI: 10.4254/wjh.v9.i4.217]
URL: https://www.wjgnet.com/1948-5182/full/v9/i4/217.htm
Number Citing Articles
1
Kenneth E. Sherman, Susan D. Rouster, Minhee Kang, Triin Umbleja, Richard Sterling, Adeel A. Butt. PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected IndividualsDigestive Diseases and Sciences 2018; 63(11): 2969 doi: 10.1007/s10620-018-5278-y
2
Jennifer J. Kiser, Darlene Lu, Susan L. Rosenkranz, Gene D. Morse, Robin DiFrancesco, Kenneth E. Sherman, Adeel A. Butt. Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309sDrugs in R&D 2017; 17(4): 557 doi: 10.1007/s40268-017-0205-9